The VALIDATE Network - Vaccine development for complex intracellular neglected pathogens
MRC Molecular & Cellular Medicine Board (MCMB) Partnership Grants, 2021
Open date: 9 Mar 2021
Deadline for applications: 5 May 2021 16:00 (UK+1)
Partnership grants provide core funds for one to five years to support partnerships between diverse groupings of researchers and can be used for infrastructure support, platform activities and for bringing together managed consortia or multidisciplinary collaborations.
The Partnership grant scheme is designed to support collaborative activities that add value to high-quality scientific programmes that are already supported by grants from the MRC and other funders. It is NOT designed to fund stand-alone, hypothesis-driven research projects, which may otherwise be eligible for MRC Research or Programme grant type funding.
Typically, successful Partnership grants include a varying combination of the following components: networking and partnership activities, underpinning infrastructure activities (either for establishing a unique resource or exploiting it), capacity building and primary research. Please refer to the Partnership grant case studies as exemplars of successful grants.
Funding can be provided for the following activities:
Establishing multi-disciplinary collaborative partnerships or consortia
Developing strategy to strengthen research activity across the field
Knowledge sharing across research departments, or between Institutions
Training, career development and capacity building (excluding fellowships but including PhD studentships, see details on ‘Studentships’ below)
Establishing shared infrastructure, for example staff, systems, equipment, seminars, workshops. This could include a co-ordinated set of needs-led and complementary networking activities (including outreach work and travel) with a defined output. Applications for funding to support only networking activities will be rejected.
Exceptionally, small scale, pilot, proof of principle, multidisciplinary, high risk projects which will strengthen the Partnerships’ strategy may be considered but should not be the focus of the application
The Molecular and Cellular Medicine Board is responsible for MRC’s investments seeking to understand the molecular and cellular mechanisms that underpin complex biological function in human health and disease, and supporting the early translation of knowledge towards new diagnosis and treatment, and changes to policy and practice. The Board seeks to extend our understanding of structure-function insights of molecules and complexes, how the cellular environment functions during development and mature states, and how biological systems respond to external insults (e.g. drugs and toxins) and disease states. The Board leads MRC’s investments in cancer, from fundamental discovery science to epidemiology, experimental medicine and early translation.
Who can apply?
The partnership must be led by a Principal Investigator (PI) based at a research organisation (RO) that is eligible to apply in response mode.
For the full call text please visit the MRC grant call webpage.